Concierge memory clinic · London
Memory problems assessment and treatment, memory-clinic pathway with cognitive testing, MRI, biomarkers and anti-amyloid therapy access.
A private memory-clinic pathway combines consultant assessment, cognitive testing (ACE-III, MoCA), MRI brain, CSF or blood biomarkers, and — where eligible — access to anti-amyloid disease-modifying therapies (lecanemab, donanemab).
Key facts
- 01
Definition
Structured memory-clinic assessment and treatment pathway.
- 02
Consultant-led
Neurology, old-age psychiatry or memory clinic.
- 03
Cognitive testing
ACE-III, MoCA, MMSE — validated instruments.
- 04
MRI brain ± volumetric
Structural imaging with BrainKey volumetric analysis where indicated.
- 05
CSF or blood biomarkers
Aβ42 and p-tau — supports or excludes an Alzheimer’s diagnosis.
- 06
Anti-amyloid access
Lecanemab, donanemab — where eligibility criteria are met.
Indicative pricing
What a private memory-clinic pathway costs in London.
Indicative ranges across our partner clinics. Send the details and we quote firm figures across two or three options.
In short
A consultant memory-clinic assessment in our network: £450–£750, with MRI and biomarkers added as clinically indicated.
| Component | Indicative range | Typical duration | Report turnaround |
|---|---|---|---|
| Consultant memory-clinic assessment | £450–£750 | 60–90 min | Same visit |
| Cognitive testing (ACE-III / MoCA) | £150–£300 | 45 min | Same visit |
| MRI brain ± volumetric analysis (BrainKey) | £600–£1,200 | 30–45 min | 24–48 h |
| CSF biomarkers (Aβ42, p-tau) | £800–£1,500 | 30 min | 1–2 weeks |
| Blood biomarkers (p-tau217) | £450–£800 | 15 min | 1–2 weeks |
| Anti-amyloid therapy assessment and pathway | On quote | Half-day | Same-week |
Prices vary by consultant, imaging protocol and which biomarkers are used. We come back with a firm quote within one working day.
How the diagnosis is reached
Seven steps from first visit to a personalised plan.
A structured memory-clinic pathway integrates consultant assessment, cognitive testing, imaging and biomarkers — reviewed as a whole.
- 01
Consultant assessment and history
Full history from patient and informant, examination, medication review.
- 02
Cognitive testing
ACE-III, MoCA or MMSE, with domain-level scores.
- 03
Blood screen
TSH, B12, folate — reversible contributors excluded.
- 04
MRI brain
Structural imaging ± volumetric analysis (BrainKey).
- 05
CSF or blood biomarkers
Aβ42, p-tau — molecular support for Alzheimer’s diagnosis.
- 06
Multi-disciplinary review
Integrated interpretation across consultant, imaging and biomarkers.
- 07
Personalised plan and support
Treatment, lifestyle, therapy and structured follow-up.
The journey
From enquiry to plan — what happens, in order.
One consultant, one memory-clinic pathway — often coordinated within days.
Phase 1 · Before your visit
Concierge, off-stage for you
Phase 2 · On the day
Consultant assessment and investigations
Phase 3 · After
MDT review and plan
- 01
Before
You tell us what’s going on
A short, confidential form. Symptoms, timeline, family history, medications, prior imaging.
- 02
Before
We come back with a recommendation
Within one working day: which consultant, memory-clinic pathway, indicative price and timeline.
- 03
Before
We arrange the appointment
Consultant clinic and MRI booked. Insurer pre-authorisation handled where relevant.
- 04
On the day
Consultant assessment
Full history from patient and, ideally, an informant. Cognitive testing on the day (ACE-III / MoCA).
- 05
On the day
Investigations
Blood screen (TSH, B12, folate), MRI brain and — where indicated — CSF or blood biomarkers.
- 06
On the day
Straight home
No hospital stay. Return to normal activities the same day.
- 07
After
MDT review and plan
Multi-disciplinary review, personalised plan and structured memory-clinic follow-up. Anti-amyloid pathway if eligible.
Typical end-to-end: 2–4 weeks. Urgent cases: same week.
What it shows
The diagnoses a memory-clinic pathway makes or excludes.
Cognitive change has many causes — some reversible, some progressive. The pathway’s job is to distinguish them and act.
-
Mild cognitive impairment
The earliest measurable stage — a window for lifestyle change and monitoring.
-
Alzheimer’s disease (amyloid + tau positive)
Biomarker-supported diagnosis, opening access to disease-modifying therapy.
-
Vascular dementia
Cognitive decline driven by cerebrovascular disease — imaging is the key.
-
Frontotemporal dementia
Behavioural or language variants, often at a younger age.
-
Dementia with Lewy bodies
Fluctuating cognition, visual hallucinations, parkinsonism.
-
Reversible causes (thyroid, B12, depression)
Treatable contributors that mimic dementia — always screened first.
-
Normal-pressure hydrocephalus
Gait, incontinence and cognition — a potentially reversible cause.
-
Red flag: rapidly progressive dementia — urgent neurology (autoimmune encephalitis, CJD)
Rapid decline over weeks to months needs urgent neurological assessment.
Treatment options
The full range of treatments a memory clinic can offer.
From lifestyle to disease-modifying therapy — what a modern memory-clinic pathway offers.
-
Lifestyle prescription (exercise, sleep, diet)
Structured, evidence-based lifestyle plan — the foundation of every pathway.
-
Cholinesterase inhibitors
Donepezil, rivastigmine or galantamine for mild-to-moderate Alzheimer’s and Lewy body dementia.
-
Memantine
NMDA receptor antagonist for moderate-to-severe Alzheimer’s disease.
-
Anti-amyloid therapy (lecanemab, donanemab)
Disease-modifying infusion therapy for eligible early-stage Alzheimer’s.
-
Cognitive stimulation therapy
Structured group programme supporting cognition and wellbeing.
-
Occupational therapy home visit
Practical adaptations for safety and independence at home.
-
Driving assessment referral
Formal assessment when driving safety is uncertain.
-
Structured memory-clinic follow-up
Regular review with the consultant and the MDT.
Our vetted London network
A small panel of consultants, we picked them.
Partners across central, north, west and south London. Not listed publicly — introductions are made privately, once we understand your case.
Selection criteria
How we choose every consultant in our network.
-
Consultant neurologists, old-age psychiatrists or memory-clinic leads
-
Validated cognitive instruments (ACE-III, MoCA, MMSE) with domain-level reporting
-
MRI brain with volumetric analysis where indicated (BrainKey or equivalent)
-
Access to CSF and blood biomarkers and — where eligible — anti-amyloid therapy pathway
Red flags and safety
The signals a memory clinic never misses.
Some patterns need urgent attention — rapid decline, safety concerns, or the specific risks of anti-amyloid therapy.
-
Rapidly progressive dementia
Rapid decline over weeks to months requires urgent neurology — autoimmune encephalitis and CJD must be excluded.
-
Autoimmune encephalitis features
Subacute cognitive decline, seizures or psychiatric change — treatable and time-critical.
-
CJD triphasic waves
Prion disease with characteristic EEG features — needs specialist review.
-
Normal-pressure hydrocephalus
Gait, incontinence and cognition triad — potentially reversible with shunting.
-
Delirium overlay
Acute confusion on top of cognitive change — must be recognised and treated separately.
-
Suicide risk in early dementia
The period around diagnosis carries real risk — formal safety-netting is built in.
-
Driving safety concerns
A duty to notify the DVLA — we support the process and arrange formal assessment.
-
Vulnerable adult
Safeguarding is considered at every step, and involved family or carers are supported.
-
Post-anti-amyloid ARIA-E/H
Amyloid-related imaging abnormalities — the reason anti-amyloid therapy requires careful monitoring.
Reading your report
A memory-clinic report can look intimidating. It isn’t.
Whatever the finding, the report keeps to the same four parts.
A quiet reminder
The report is written for your doctor, not for you — and that’s normal.
If you would like us to talk you through it before your follow-up, just ask.
- 01 Header
History and cognitive scores
Your details, informant history, medication review and cognitive test scores.
- 02 Imaging
MRI brain ± volumetric findings
Structural imaging with hippocampal and cortical volume analysis where performed.
- 03 Biomarkers
CSF or blood: Aβ42, p-tau, ratios
Molecular biomarkers with reference ranges and interpretation.
- 04 Impression
Diagnosis and plan: read this first
Diagnosis, treatment plan, follow-up and — if eligible — anti-amyloid pathway.
Recognised by major UK insurers
Cover depends on your policy and consultant; we confirm with your insurer before booking.
Frequently asked
Everything we get asked about memory-clinic assessment.
Quick answers on cognitive testing, biomarkers, anti-amyloid therapy, cost and referrals.
-
What happens in a private memory-clinic assessment?
A consultant takes a full history from you and, ideally, someone who knows you well. Cognitive tests (ACE-III or MoCA) are done on the day, alongside a blood screen. MRI brain is arranged, and — where indicated — CSF or blood biomarkers (Aβ42, p-tau). The findings are reviewed at an MDT and a personalised plan is agreed.
-
What is the ACE-III?
The Addenbrooke’s Cognitive Examination III is a validated 100-point cognitive assessment covering attention, memory, fluency, language and visuospatial function — the domain-level scores matter more than the total.
-
What is anti-amyloid therapy?
Lecanemab and donanemab are disease-modifying antibody therapies that clear amyloid plaques from the brain. They are given by infusion and slow the progression of early Alzheimer’s disease in eligible patients. Access requires biomarker confirmation and careful monitoring for amyloid-related imaging abnormalities (ARIA).
-
Am I eligible for lecanemab or donanemab?
Eligibility requires biomarker-confirmed Alzheimer’s pathology (amyloid positive), early clinical stage (MCI or mild dementia), and no absolute contraindications on MRI. The memory-clinic pathway confirms this.
-
How much does a private memory-clinic assessment cost in London?
A consultant memory-clinic assessment is typically £450–£750, with additional costs for MRI (£600–£1,200) and biomarkers (£450–£1,500). We come back with a firm figure within one working day.
-
Do I need a referral?
Most consultants accept self-referral for a private memory-clinic assessment. We can arrange a fast-track private GP referral if needed for insurance or onward pathway.
Sources and reviewers
- NICE. Dementia: assessment, management and support for people living with dementia and their carers (NG97).
- Alzheimer’s Association. Appropriate use criteria for lecanemab and donanemab.
- Royal College of Psychiatrists (Old Age Faculty). Memory service standards.
- Alzheimer’s Research UK. Diagnosis and treatment overview.
Reviewed by Pulse Atlas Editorial Board (). Next scheduled review: 2027-07-30.
Related tests
Looking for a different test?
-
BrainKey scan
MRI brain with volumetric analysis for hippocampal and cortical volumes.
Learn more -
Amyloid scan
PET imaging for amyloid plaques — a molecular Alzheimer’s marker.
Learn more -
Brain MRI
High-resolution MRI of the brain for structural assessment.
Learn more -
All tests
Browse every test and procedure we arrange.
Learn more -
Tinnitus
Related condition guide.
Learn more -
Chronic Sinusitis
Related condition guide.
Learn more -
Cochlear Implants
Related treatment option.
Learn more -
Cholesteatoma Surgery
Related treatment option.
Learn more
In practice, in London
Why private memory problems assessment and treatment moves differently in London
With memory problems assessment and treatment, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. The wait for memory problems assessment and treatment on the NHS depends heavily on where you live and how urgently the referral is graded. Central and West London private clinics can normally book within a week, with imaging or a procedure slot to follow shortly after. It’s worth being honest about the reason for going private: usually it’s time, not a fundamentally different test.
In practice, a private memory problems assessment and treatment appointment in London means a named consultant, a proper hour in the room (or the equivalent on a video call), and a report you can actually read. Most of the imaging suites and endoscopy units we use sit within a mile of Harley Street or in Chelsea and Fulham, and turnaround on findings is measured in days, not weeks. For memory problems assessment and treatment specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.
Where a good concierge earns its keep is in the matching. There are dozens of consultants in London who see memory problems assessment and treatment — but not all of them are the right fit for every case. We narrow it down based on subspecialty, insurer coverage, the specific question being asked, and whether continuity into treatment matters. The right first appointment saves you from repeating yourself later.
Nearby in the library